CLENPIQ
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
Approval overview CLENPIQ is listed in Drugs@FDA under application 209589 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE Form and strength SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT Sponsor FERRING PHARMS INC Submission history Latest submission status date: 2023-08-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview CLENPIQ is listed in Drugs@FDA under application 209589 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE Form and strength SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT Sponsor FERRING PHARMS INC Submission history Latest submission status date: 2023-08-29 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.